pAbT4660 (40866)

Depositors: Therion Biologics Corporation, R Emyanitoff, Therion Biologics Corporation

Permits and Restrictions

View Permits

Designations pAbT4660
U.S. Patent
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Depositors Therion Biologics Corporation, R Emyanitoff, Therion Biologics Corporation
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Media ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
Growth Conditions
Temperature: 37.0°C
References

Payne L. Self-assembling replication defective hybrid virus particles. US Patent 5,420,026 dated May 30 1995

Product Sheet
Product Sheet
Product Sheet